Your cart is empty
Add research compounds to get started.

Dual Incretin Receptor Agonist
Tirzepatide is a novel single molecule that acts as a dual agonist at both the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. Its unique dual-incretin mechanism makes it a subject of significant interest in metabolic research.
Research Use Only. This compound is sold for laboratory and research purposes only. Not for human consumption, veterinary use, or therapeutic application.
Peer-reviewed literature for Tirzepatide